i-SENS Inc

i-SENS Inc

099190 · KQ · Healthcare / Healthcare Equipment & Supplies

13,030.00KRW-290.00 (-2.18%)

Price History

Full chart

Market Stats

Previous Close13,320.00
Open13,450.00
Day Range12,920.00 – 13,680.00
52-Week Range14,000.00 – 27,600.00
Volume40.02K
Market Cap487.13B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.53%
Beta0.42
50-Day Avg17,074.80
200-Day Avg18,059.10

About

i-SENS, Inc. provides diagnostic biosensors in South Korea. The company offers point of care testing devices, such as HbA1c, blood gas, electrolyte, and PT/INR analyzers; CareSens blood glucose monitoring systems; and lancing and other ancillary devices, as well as diabetes management services. It exports its products to approximately 110 countries, including the United States, Japan, and Europe. The company was founded in 2000 and is headquartered in Seoul, South Korea.

Company Details

  • SectorHealthcare
  • IndustryHealthcare Equipment & Supplies
  • CEODr. Geun-Sig Cha
  • Employees0
  • Headquarters43, Banpo-daero 28-gil, Seoul, South Korea, 06646, Korea
  • Websitehttp://www.i-sens.com

Leadership

  • Dr. Geun-Sig ChaFounder, Chairman & CEO · b. 1954
  • Dr. Hak-Hyun Nam Ph.D.Founder, CTO & Director · b. 1959
  • Mr. Za Soo LeeChief Marketing Officer · b. 1961
  • Mr. Gang Se LeeDirector of Sales & Marketing · b. 1969
  • Ms. Jung-won ShinManaging Director · b. 1968
  • Mr. Sang-Ju LeeManaging Director · b. 1966

Financials

Income Statement

Currency: KRW2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue66.55B82.86B95.61B101.92B132.47B156.96B173.00B189.84B203.71B232.93B264.84B265.12B291.14B315.44B
Growth (%)-+24.51%+15.38%+6.60%+29.97%+18.49%+10.21%+9.74%+7.30%+14.35%+13.70%+0.11%+9.81%+8.35%
Cost of Revenue39.58B42.15B49.22B56.52B70.64B87.76B95.27B103.06B107.92B130.87B159.35B159.06B177.60B190.18B
Gross Profit--40.42B45.40B61.83B69.20B77.72B86.78B95.79B102.06B105.49B106.06B113.53B125.26B
Gross Margin--42.28%44.54%46.68%44.09%44.93%45.71%47.02%43.82%39.83%40.00%39.00%39.71%
Operating Expense--22.30B23.96B36.96B45.85B50.32B55.98B56.79B67.16B85.49B98.87B118.51B117.37B
Operating Income7.94B18.56B18.12B21.44B24.87B23.35B27.40B30.80B39.00B34.90B19.99B7.18B-4.98B7.89B
Operating Margin11.93%22.39%18.96%21.04%18.77%14.88%15.84%16.22%19.14%14.98%7.55%2.71%-1.71%2.50%
EBITDA----------33.08B22.68B24.43B13.72B
EBITDA Margin----------12.49%8.55%8.39%4.35%
Net Income8.74B18.64B14.47B14.72B17.56B15.73B22.62B23.43B26.84B25.45B16.14B3.71B-1.79B-5.15B
Net Income Margin13.14%22.50%15.13%14.44%13.26%10.02%13.07%12.34%13.18%10.93%6.09%1.40%-0.62%-1.63%
R&D5.18B6.30B8.54B9.79B11.83B13.61B13.35B16.48B18.91B21.89B26.97B27.00B30.26B32.65B
R&D as % of Total Revenue7.79%7.60%8.93%9.61%8.93%8.67%7.72%8.68%9.29%9.40%10.19%10.18%10.39%10.35%
Interest Expense00000001.40B1.04B856.24M1.87B2.98B6.86B7.20B
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.74%0.51%0.37%0.71%1.12%2.36%2.28%

Balance Sheet

Currency: KRW2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets92.05B141.41B163.51B179.80B215.07B234.08B252.05B270.04B307.03B429.18B449.57B498.82B590.87B577.66B
Total Liabilities23.61B37.10B44.70B47.78B65.39B71.28B71.12B71.48B87.54B160.85B163.76B195.32B247.89B239.34B
Total Equity68.44B103.13B117.61B132.02B149.67B162.80B180.93B198.56B219.49B268.33B285.81B284.35B324.70B315.25B
Cash1.64B8.95B25.35B23.16B25.50B27.46B27.01B34.46B30.52B7.18M13.81M45.33B67.64B45.00B
Total Debt---28.05B35.22B42.03B38.62B20.60B44.61B-----
Net Debt--------16.70B51.54B35.52B93.48B101.56B125.79B

Cash Flow

Currency: KRW2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow5.10B16.19B17.85B22.56B11.73B22.38B19.54B37.95B34.61B17.22B6.65B13.05B22.96B20.12B
Investing Cash Flow---8.62B-24.53B-14.20B-27.92B-12.59B-19.36B-46.19B-59.57B16.50B-63.78B-40.30B-
Financing Cash Flow1.63B27.11B6.84B-58.52M4.18B8.19B-8.20B-11.04B9.63B58.25B-9.22B34.94B38.78B-
Capital Expenditure15.49B28.44B7.91B13.75B8.59B23.66B8.82B6.93B7.64B47.63B23.27B42.65B15.58B28.46B
Free Cash Flow--------26.61B-30.97B-16.61B-29.60B7.38B-8.34B
Dividends Paid--1.37B1.37B1.37B1.37B1.37B2.04B2.72B3.40B4.08B4.81B2.75B2.76B
FCF to OCF--------76.88%-179.81%-249.71%-226.93%32.14%-41.44%
Dividend Paid to FCF--------10.22%-10.97%-24.55%-16.23%37.28%-33.15%

Earnings

Report DateMay 29, 2013Aug 28, 2013Nov 27, 2013Feb 26, 2014May 28, 2014Aug 29, 2014Nov 28, 2014Mar 19, 2015Apr 29, 2015Aug 17, 2015Nov 13, 2015Jan 27, 2016May 16, 2016Aug 16, 2016Nov 11, 2016Mar 16, 2017Apr 26, 2017Aug 14, 2017Nov 14, 2017Feb 4, 2018May 15, 2018Aug 14, 2018Nov 14, 2018Feb 14, 2019May 15, 2019Aug 5, 2019Nov 4, 2019Feb 4, 2020May 7, 2020Aug 3, 2020Oct 27, 2020Feb 3, 2021Apr 29, 2021Jul 27, 2021Oct 27, 2021Jan 27, 2022May 2, 2022Jul 28, 2022Oct 28, 2022Apr 28, 2023Jul 28, 2023Nov 3, 2023Feb 13, 2024May 3, 2024Jul 31, 2024Nov 1, 2024Apr 29, 2025Jul 29, 2025Oct 30, 2025Dec 31, 2025Apr 27, 2026Jun 30, 2026
EPS Estimate----157.67176.67212.67188.00-171.27165.76-176.35173.57211.19276.67346.81197.93189.01366.21166.68176.00147.04393.08161.49266.23620.00-------------192.16100.17194.71---------
EPS Actual120.63168.57192.85202.00117.33102.40125.00131.67100.92100.89111.00169.00136.00129.00186.50184.50144.00188.00137.00322.00116.00157.00243.00616.00190.50870.00607.00-159.65478.00524.00447.00523.68255.50325.50256.5097.64474.5088.0072.50-46.72100.00-31.00-87.87-9.50-0.0930.65-86.1331.45-14.34-297.9769.76136.71
Surprise-----25.59%-42.04%-41.22%-29.96%--41.09%-33.04%--22.88%-25.68%-11.69%-33.31%-58.48%-5.02%-27.52%-12.07%-30.41%-10.80%65.26%56.71%17.96%226.79%-2.10%--------------47.96%-130.95%-145.13%---------
Timing----After-hours-Pre-marketAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hours-Pre-marketAfter-hours-After-hoursPre-marketAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursPre-marketPre-marketPre-market-Pre-market-

Key Statistics & Ratios

Market Cap487.13B
Enterprise Value538.91B
Trailing P/E0.00
Forward P/E0.00
Price / Sales1.36
Price / Book1.34
Revenue (TTM)262.07B
Gross Profit (TTM)102.06B
EBITDA37.55B
Profit Margin7.66%
Operating Margin10.00%
Return on Equity35.25%
Return on Assets4.06%
Shares Outstanding13.74M
Shares Float8.88M
Beta0.42
Dividend Yield0.53%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20251×
100.00Dec 29, 2025
20241×
100.00Dec 27, 2024
20231×
100.00Dec 27, 2023
20221×
175.00Dec 28, 2022
20211×
150.00Dec 29, 2021
20201×
125.00Dec 29, 2020
20191×
100.00Dec 27, 2019
20181×
75.00Dec 27, 2018
20171×
50.00Dec 27, 2017
20161×
50.00Dec 28, 2016

Stock Splits

  • Mar 14, 20232:1
  • Sep 7, 20153:2